Zong et al. [55] demonstrated that bone marrow mice cells Mdr1a/1b-null transduced with BCR-ABL display a similar response to imatinib, which is related to increased peripheral white blood cells counts and marked hepatosplenomegaly, compared with BCR-ABL-transduced wild-type bone marrow. This evidence concerns the gene ABL1 and Hepatosplenomegaly.